Skip to main navigation

Live - Top Menu

  • Clinical Trials
  • Investors & Media
  • Careers
  • Contact Us
Menu
Close

Main navigation

  • Our Focus
  • Our Research
  • Our Medicine
  • Our Story
Home > Investors & Media > Financial Information > SEC Filings
  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
    • Financial Information
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
    • Contact Us

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter

SEC Filings

SEC Filings

Filing date Form Description View
Aug 14, 2020 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-20-095693.pdf
0001104659-20-095693.rtf
0001104659-20-095693.xls
Aug 11, 2020 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-20-093397.pdf
0001104659-20-093397.rtf
0001104659-20-093397.xls
Aug 10, 2020 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-20-092382.pdf
0001104659-20-092382.rtf
0001104659-20-092382.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Aug 10, 2020 10-Q

Quarterly report which provides a continuing view of a company's financial position

View HTML
0001558370-20-010181.pdf
0001558370-20-010181.rtf
0001558370-20-010181.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jul 17, 2020 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-20-084548.pdf
0001104659-20-084548.rtf
0001104659-20-084548.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jul 15, 2020 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-20-083785.pdf
0001104659-20-083785.rtf
0001104659-20-083785.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jul 06, 2020 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-20-081430.pdf
0001104659-20-081430.rtf
0001104659-20-081430.xls
Jul 06, 2020 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-20-081432.pdf
0001104659-20-081432.rtf
0001104659-20-081432.xls
Jul 06, 2020 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-20-081440.pdf
0001104659-20-081440.rtf
0001104659-20-081440.xls
Jul 06, 2020 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-20-081438.pdf
0001104659-20-081438.rtf
0001104659-20-081438.xls

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Current page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »

Data provided by Kaleidoscope.

  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
    • Financial Information
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
    • Contact Us

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter

Live - Footer Menu

  • Privacy Policy
  • Privacy Shield Policy
  • Corporate Compliance
  • Terms of Use
  • Contact Us
  • Cookie Preferences
10 Hudson Yards, 37th Floor|New York, NY 10001|T: 844-782-ICPT
© 2020 Intercept Pharmaceuticals, Inc.